Turning DNA Knowledge Into Preventive Health Habits: nutriADN

Q: What opportunities do genomic insights bring to Mexico’s healthcare system?

A: Genomic medicine is only beginning to take off in Mexico. It is only in recent years that there has been a greater awareness that genetics is not only useful for diagnosing rare diseases, but is now a fundamental pillar for knowledge of oneself. From preventive care to personal insight, genetics enables a much more active approach to prevention. It plays a role in cardiovascular health, oncology, drug response, and in understanding any predisposition a person might have, empowering individuals to take a more proactive and engaged role in their care, in partnership with their physician.

The European Union and Asia have made significant advances in this area. The same is true, to a large extent, in the United States. Mexico is only now seeing the emergence of the first genomic medicine laboratories. Unfortunately, genomic medicine is a field driven by volume, and the Mexican market has not yet reached the scale required for full development. Once it surpasses those critical volume thresholds, this field will become significantly more accessible and democratic, with lower costs and greater availability for all. 

Our opportunity lies in how we communicate this value. Genetics should not be seen as a source of fear or anxiety. Like in many areas of life, information is power. If we care about our health and are conscious of the need to protect it, then understanding our genetic profile is one of the most powerful ways to begin.

Q: What are the most common misconceptions or knowledge gaps regarding genetics among the general public?

A: One common misconception is that genetics provides us with a snapshot of our health. In reality, genetics represents just one part of our overall health. The impact of genetic predispositions varies depending on the condition. In many cases, what truly runs in families are not the genes, but the habits, as  is often the case with diabetes. In contrast, when someone has a family history of high LDL cholesterol, that is typically a genetic factor. Their body simply produces more LDL cholesterol than average, regardless of lifestyle. This highlights one of the most common myths, that genetics alone determines our destiny.

Another misconception is that genetics predicts the future. It does not tell us if we will get sick, but rather what genetic predispositions we carry. It is our lifestyle, or epigenetics, the expression of our genes, that will determine whether or not those traits are activated over time. This is why understanding genetics is so important. It allows us to make informed changes to our habits and take control of our health in a proactive and personalized way.

Q: How aware is the Mexican population about the benefits offered by genetic testing and personalized health solutions?

A: There is now a much greater awareness on two fronts. First, there is an increasing body of scientific evidence that supports the relevance and value of genetics. Second, the general public has become more aware of the importance of DNA. It is, in essence, an original blueprint that reveals specific needs and areas of vulnerability. People are beginning to understand that knowing this information allows them to take more targeted and preventive action when it comes to their health.

We serve two primary audiences: healthcare professionals and the broader population. We host an annual conference for healthcare professionals and this year we will hold the second edition of the Congress on Nutritional and Functional Genomics. This event explores key areas where genetics is already being applied, such as fertility, skin health, digestive wellness, and hormonal balance, among others. Genetics has become a foundational pillar in understanding and personalizing care across these domains. We have made large efforts to raise awareness and to educate healthcare professionals. We are at a critical point where this field is poised for broader development and integration.

Q: How does nutriADN plan to stay at the forefront of the industry and maintain its leadership position?

A: As Mexico’s genomic health market continues to expand, we are seeing competition increase, particularly from international companies. However, many of these players have struggled to gain traction, as this is a sector that demands long-term vision, deep expertise, and sustained investment. Over the past nine years, we have built a differentiated model rooted in education and innovation. We began with a simple, accessible nutrigenetic test designed to help individuals understand their unique nutritional, exercise, and lifestyle needs. From there, we expanded into more complex areas such as gut microbiome analysis, a powerful tool for identifying the root causes of digestive, immune, dermatological, and even neurological conditions. We also entered the field of hormonal health, developing solutions to monitor hormone behavior and guide treatment through functional medicine principles.

This evolution led us to create a line of specialized nutritional supplements tailored to the specific needs we observed among our patient population. Each product is developed in collaboration with healthcare professionals and is formulated to target conditions such as endometriosis, insulin resistance, fertility, and stress. We are now preparing to launch a digital health platform that integrates genetic data, clinical history, lifestyle habits, and biometric tracking. This platform will lay the foundation for a future mobile application powered by AI, offering personalized recommendations to both patients and professionals in real time.

Our integrated, multi-pillar approach, spanning diagnostics, supplementation, clinical services, and digital health, has positioned us as a leader in the field. While we recognize that others may seek to replicate what we have built, we also know that true differentiation requires consistency, depth, and a strong commitment to long-term impact. 

Q: Beyond tests, what are the main benefits clients can obtain when they visit nutriADN’s clinics?

A: We started with one clinic in Monterrey and now have two offices there, as well as clinics in Mexico City, Guadalajara, and Tijuana. In July, we are opening a new location in Puebla. This expansion enables more people to get more than just a genetic test. Patients can now visit a clinic, provide their sample, receive a personalized interpretation, undergo a full body composition analysis, and access the specific supplements they need, all in one place.

Q: What reasons led to the creation of nutriADN 360 and how does it differentiate from your other services?

A: The concept behind nutriADN 360 had been in development since last year and officially launched in January 2025. Health is not a one-time solution; it is an ongoing process that must be maintained and adapted over time. Four years ago, we launched our original nutriADN programs, which combined genetic testing with six months of personalized nutrition and physical activity consultations. While the results were impactful, we noticed that after six months, many patients would thank us and move on. However, their journey to optimal health was often just beginning.  This led us to design nutriADN 360, a continuous, evolving wellness program that accompanies patients beyond their initial concerns. The idea is to not only resolve existing symptoms, but to use genetic insights to personalize nutrition, exercise, supplementation, and preventive strategies throughout every stage of life.

Ultimately, we aim to guide patients toward longevity. Once key systems are optimized, the next step is to slow down biological aging. To that end, we developed the AgeTest, which assesses biological age versus chronological age and offers personalized recommendations for optimizing cardiovascular, cognitive, and skeletal health, particularly for individuals entering their 60s and 70s who wish to preserve muscle mass, bone density, and vitality. We have begun implementing this model in the corporate world. We are now working with large organizations, including financial institutions and banks, to offer executive wellness programs. 

Q: What steps have been taken to embed nutriADN into the insurance sector’s preventive care offer?

A: In the European Union, life insurance policies often include genetic testing as a tool for promoting healthier habits and offering added value. We are only now beginning to revisit this model. The digital platform we are launching in July will be a key enabler. It will allow us to reengage with brokers, insurers, and corporate clients at scale. It will also meet a critical need we heard repeatedly, which is geographic reach. We are expanding our footprint across more cities in Mexico, which positions us to serve both individual users and large institutions nationwide. 

Q: What role will nutriADN play in shaping the future of healthcare in Mexico, particularly as the system begins to prioritize prevention and digital tools?

A: The ultimate goal is for NutriADN to become the go-to health clinic for every individual, not a place people turn to only when they are already ill or facing a medical emergency, but a trusted center for proactive, preventive care.

We want to shift the paradigm away from reactive medicine. NutriADN is designed to be a clinic focused on preventive and lifestyle medicine, grounded in functional health. Our aim is to make this kind of personalized, proactive care accessible and affordable for everyone. NutriADN can support people across all sectors, whether they are individuals, employees within a company, or healthcare professionals themselves. Our broader objective is to create an ecosystem and drive a change in mindset: health does not begin when one gets sick, health begins every day with habits, nutrition, thoughts, environment, sleep, and care for the body and mind.

nutriADN offers preventive and personalized solutions tailored to individual genetic profiles, balancing nutrition, exercise, and functional medicine.